Search for: "GLAXOSMITHKLINE LLC"
Results 21 - 40
of 181
Sort by Relevance
|
Sort by Date
17 Jul 2022, 5:00 am
GlaxoSmithKline LLC, SCT Docket No. 22-37 (2022). [read post]
6 May 2022, 8:10 am
Cir. 2021), en banc denied at GlaxoSmithKline LLC v. [read post]
10 Apr 2022, 12:58 pm
Meso Scale Diagnostics, LLC, 2022 WL 1052320, — 4th — (Fed. [read post]
28 Feb 2022, 2:00 am
No. 18-1976, SSRN (2021): In GlaxoSmithKline LLC v. [read post]
15 Feb 2022, 9:03 pm
Federal Circuit Denies En Banc Review in GlaxoSmithKline LLC v. [read post]
14 Feb 2022, 9:38 am
by Dennis Crouch GlaxoSmithKline LLC v. [read post]
4 Nov 2021, 7:03 pm
The health care industry is no longer limited to doctors and hospitals, but a veritable thicket of holding companies, LLCs, and private equity firms. [read post]
14 Oct 2021, 4:15 am
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
14 Oct 2021, 4:15 am
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
24 Aug 2021, 2:10 am
Teva GlaxoSmithKline LLC v. [read post]
13 Aug 2021, 6:43 am
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, No. 20-cv-09077-JSW, 2021 WL 3524047 (N.D. [read post]
12 Aug 2021, 8:59 pm
By Kevin E. [read post]
5 Aug 2021, 12:12 pm
GlaxoSmithKline LLC v. [read post]
14 Jul 2021, 8:09 pm
The background of the opinion describes the rather complex set of issues: We describe the facts in the light most favorable to the party that won the jury verdict (here, the plaintiffs). [read post]
25 Jun 2021, 4:15 am
LLC (Sanofi). [read post]
16 Mar 2021, 6:00 am
To the Open Source Hardware (OSHW) community, the Federal Circuit’s October opinion in the ongoing appeal of GlaxoSmithKline LLC v. [read post]
10 Feb 2021, 7:12 pm
GlaxoSmithKline LLC v. [read post]
10 Feb 2021, 8:54 am
The case is GlaxoSmithKline LLC v. [read post]
26 Jan 2021, 8:11 am
Amgen, GlaxoSmithKline (GSK) and a group of intellectual property professors filed a trio of amicus briefs placing their support behind Idenix, warning that the future of innovation was on the line. [read post]
22 Jan 2021, 2:00 am
Carrier (Rutgers Law School), Matthew J Dowd, Robert Scheffel, Corrected Brief of Amici Curiae Fifty-Seven Law, Economics, Business, Health, and Medicine Professors in Support of Cross-Appellant's Petition for Rehearing En Banc, Federal Circuit brief in GlaxoSmithKline LLC v.... [read post]
